Matthew Lanchantin

Matthew Lanchantin is currently the Head of Corporate Development at Syntis Bio. With a background in bioengineering and experience in various roles within the biotech industry, including partnerships, licensing, and corporate strategy, Matthew is also a Co-Founder and Board Director at Nucleate Bio. Matthew holds an MBA from MIT Sloan School of Management and a BS in Chemical and Biological Engineering from Tufts University.